Form CORRESP - Correspondence:
SEC Accession No. 0001193125-21-265928
Filing Date
2021-09-07
Accepted
2021-09-07 06:07:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6130
  Complete submission text file 0001193125-21-265928.txt   7151
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations